SCAMP3 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL4699731	1.00	2/20
SCHEMBL16111548	1.00	2/20
SCHEMBL29358745	1.00	2/20
SCHEMBL29380618	1.00	2/20
SCHEMBL29931136	1.00	2/20
SCHEMBL4697866	0.89	2/20
SCHEMBL24532075	0.89	2/20
SCHEMBL4697696	0.86	2/20
SCHEMBL23092285	0.86	2/20
SCHEMBL29688472	0.86	2/20
SCHEMBL22024695	0.86	2/20
SCHEMBL16136600	0.84	2/20
SCHEMBL24532058	0.83	2/20
SCHEMBL4699947	0.83	2/20
SCHEMBL22025026	0.82	2/20
SCHEMBL22119546	0.82	2/20
SCHEMBL24532062	0.82	2/20
SCHEMBL18804561	0.81	2/20
SCHEMBL22024561	0.81	2/20
SCHEMBL22025030	0.81	2/20

Clinical trials — most relevant to SCAMP3 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Comparison Between Botox and Magnesium Sulfate Effect in Treatment of Myofascial Pain Trigger Points Within the Masseter Muscle	PHASE2/PHASE3	NOT_YET_RECRUITING
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)	PHASE1/PHASE2	RECRUITING
Ambroxol as a Treatment for Parkinson's Disease Dementia	PHASE2	UNKNOWN
Neuropsychiatry and Cognition in SCA3/MJD	nan	UNKNOWN
Docosahexaenoic Acid (DHA) Replacement for Treatment in Spinocerebellar Ataxia 38	nan	COMPLETED
Hong Kong Spinocerebellar Ataxias Registry	nan	RECRUITING
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease	nan	RECRUITING
Genetic Regulation of Surfactant Deficiency	nan	COMPLETED
Genetic Mechanism of Conserved Ancestral Haplotype in SCA10	nan	UNKNOWN
sCD163 in ALS Patients	nan	COMPLETED
Efficacy Of Oral Trehalose In Spinocerebellar Ataxia 3	nan	UNKNOWN
Identification of New Biomarkers of Insulin Resistance	nan	ACTIVE_NOT_RECRUITING
Identification of Biomarkers in Spinocerebellar Ataxia 3	nan	COMPLETED
Genetic Characterization of Parkinson's Disease	nan	COMPLETED
Natural History Study of FDXR Mutation-related Mitochondriopathy	nan	COMPLETED
Hydroxychloroquin (HCQ) in chILD of Genetic Defect	nan	COMPLETED
Genetic Analysis of Hereditary Disorders of Hearing and Balance	nan	COMPLETED
Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders	nan	RECRUITING
Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)	nan	RECRUITING
CoMPaSS-NMD - Computational Models for New Patients Stratification Strategies of HNMD	nan	ENROLLING_BY_INVITATION
Biomarker Research in Inherited Movement Disorders	nan	RECRUITING
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others	nan	RECRUITING
Core Stability Exercises and Hereditary Ataxia	nan	COMPLETED
Genomics of Sudden Cardiac Arrest	nan	ACTIVE_NOT_RECRUITING
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)	nan	COMPLETED
Stem Cell Models of Best Disease and Other Retinal Degenerative Diseases.	nan	COMPLETED
Study of Constitutional Platelet Disease	nan	UNKNOWN
Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias	nan	COMPLETED
Clinical Trial Readiness for SCA1 and SCA3	nan	UNKNOWN
Evaluation of CEMIP in Pancreatic Cancer	nan	UNKNOWN

Related proteins — ESM-2 sequence neighbours (a SCAMP3 binder may also engage these)

Protein	Name	Similarity
Q58DR5	—	1.000	Q58DR5 →
Q9ERN0	—	0.999	Q9ERN0 →
O35609	—	0.999	O35609 →
Q9SXA5	—	0.996	Q9SXA5 →
Q9M5P2	—	0.995	Q9M5P2 →
Q9ZTX0	—	0.992	Q9ZTX0 →
Q9SKT3	—	0.992	Q9SKT3 →
Q0JAI9	—	0.987	Q0JAI9 →
Q8H5X5	—	0.986	Q8H5X5 →
SCAMP2	Secretory carrier-associated membrane protein 2	0.985	landscape →
Q7F613	—	0.985	Q7F613 →
Q75IC7	—	0.982	Q75IC7 →
Q60EA5	—	0.982	Q60EA5 →
A2YMP7	—	0.982	A2YMP7 →
Q9LR68	—	0.981	Q9LR68 →
Q9C6X2	—	0.981	Q9C6X2 →
O77735	—	0.979	O77735 →
O15126	—	0.978	O15126 →
Q6Z8F5	—	0.978	Q6Z8F5 →
Q29BL9	—	0.977	Q29BL9 →
Q8MRQ4	—	0.976	Q8MRQ4 →
Q9VPB1	—	0.975	Q9VPB1 →
B4LIH0	—	0.975	B4LIH0 →
Q95T12	—	0.975	Q95T12 →
A7S641	—	0.974	A7S641 →
Q28F21	—	0.974	Q28F21 →
Q8K021	—	0.973	Q8K021 →
A9JS49	—	0.973	A9JS49 →
Q08DK0	—	0.973	Q08DK0 →
P56603	—	0.973	P56603 →